Literature DB >> 25262700

X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.

Yang Chen1, Tianyu Li, Jie Li, Zengnan Mo.   

Abstract

Prostate cancer (Pca) is one of the noncutaneous cancers occurring worldwide. Its high morbidity and mortality make it a concern. X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism (rs25487) has been reported to be related to Pca. However, the conclusions are controversial. In this study, PubMed, HuGENet and Chinese National Knowledge Infrastructure (CNKI) databases were combined with a comprehensive literature search. Four models including dominant (AA + AG vs. GG), recessive (AA vs. AG+GG), codominant (AA vs. AG, AA vs. GG) and per-allele analysis (A vs. G) were applied. Finally, 15 studies with 18 sets of data were included. A positive association was discovered in pooled results for recessive (odds ratio [OR]=1.202, 95% confidence interval [95% CI], 1.060-1.363, I2=46.20%), codominant (AA vs. AG; OR=1.258, 95% CI, 1.099-1.439, I2=38.50%; AA vs. GG; OR=1.283, 95% CI, 1.027-1.602, I2=51.70%) and allele analysis (OR=1.116, 95% CI, 1.001-1.244, I2=58.00%). In ethnicity subgroup analysis, these 4 models were also significant in the Asian subgroup. However, for whites, only 2 models seemed to be significant (AA vs. AG+GG: OR=1.525, 95% CI, 1.111-2.093, I2=52.60%; AA vs. AG: OR=1.678, 95% CI, 1.185-2.375, I2=30.70%). In further analysis, we regrouped the data based on race, in which pooled results and Asian subgroup were again shown to be positive. In the next analysis, expression quantitative trait loci (eQTL), linkage disequilibrium (LD), TagSNP and functional analysis were used. The results showed that the SNP was a tag and functional SNP with LD block in both Asians and whites. In summary, we suggest that XRCC1 Arg399Gln might be significantly associated with development of Pca.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25262700     DOI: 10.5301/jbm.5000111

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  3 in total

1.  Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.

Authors:  Mengle Peng; Xueliang Zhou; Xianfei Ding; Liqiang Wei; Yong Zhao; Tao Zhu; Xiaoqing Shi; Dongchun Qin
Journal:  Rheumatol Int       Date:  2016-11-03       Impact factor: 2.631

2.  Impact of polymorphisms of the DNA repair gene XRCC1 and their role in the risk of prostate cancer.

Authors:  Haipeng Zhu; Tao Jiu; Dong Wang
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

Review 3.  XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis.

Authors:  Zhuo Zhang; Qian Xiang; Guangyan Mu; Qiufen Xie; Shuqing Chen; Shuang Zhou; Kun Hu; Yi-Min Cui
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.